Frontlight ResearchEarly access
Trial site
Cardiff
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Chronic spontaneous urticaria2 trials
- Huntington's disease2 trials
- Familial hypercholesterolaemia1 trial
- Hidradenitis suppurativa1 trial
- Multiple sclerosis1 trial
- Myelodysplastic syndromes1 trial
- Phase
- Phase 39 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting6 trials
- Completed5 trials
- Recruiting1 trial
- Lead sponsor
- Novartis Pharmaceuticals12 trials
Running trials
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Huntington's disease1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 15 Nov 2026